Showing results (891-900 of 905) with videos related to

Sort By:
Pageof 91
Schizophrenia Research|February 4, 2026
Aberrant motor cortical plasticity in antipsychotic-resistant schizophrenia: A cross-sectional study using transcranial direct current and magnetic stimulationKiran Bagali, Chithra Uppinkudru, Harsh Pathak, et al.
Clinical Pharmacokinetics|June 9, 2021
Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis PatientsLuka Verrest, Monique Wasunna, Gilbert Kokwaro, et al.
Frontiers in Cellular and Infection Microbiology|January 9, 2019
Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal LeishmaniasisTegwen Marlais, Tapan Bhattacharyya, Om Prakash Singh, et al.
Public Health Challenges|June 11, 2025
Top ten public health challenges to track in 2022Don Eliseo Iii Lucero-Prisno, M B N Kouwenhoven, Yusuff Adebayo Adebisi, et al.
Molecular Psychiatry|June 29, 2023
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidineSourav Khanra, Preethi Reddy, Anna Giménez-Palomo, et al.
The New England Journal of Medicine|August 2, 2023
Duration of Adjunctive Antidepressant Maintenance in Bipolar I DepressionLakshmi N Yatham, Shyam Sundar Arumugham, Muralidharan Kesavan, et al.
International Clinical Psychopharmacology|May 21, 2020
Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum DisordersNaomi A Fineberg, Eric Hollander, Stefano Pallanti, et al.
Parasites & Vectors|January 28, 2016
Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, IndiaMary M Cameron, Alvaro Acosta-Serrano, Caryn Bern, et al.
Elife|March 23, 2016
Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinentHideo Imamura, Tim Downing, Frederik Van den Broeck, et al.
Cell Reports|February 27, 2020
Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral LeishmaniasisRajiv Kumar, Patrick T Bunn, Siddharth Sankar Singh, et al.
Pageof 91